Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Diabetes exacerbates SARS-CoV-2 replication through ineffective pulmonary interferon responses, delayed cell-mediated immunity, and disruption of leptin signaling
doi: 10.3389/fcimb.2025.1513687
Figure Lengend Snippet: Silencing of the leptin receptor in A459-hACE2 cells enhances SARS-CoV-2 replication in the presence of high leptin levels. (A) Experiment design for evaluating the effect of LEPR-deficiency and high concentration of leptin on SARS-CoV-2 replication in vitro . A549-hACE2 were seeded on 24-well plates and treated with anti-LEPR siRNA (A549-hACE2 LEPR- ) or a control siRNA (A549-hACE2 CTL ), followed by the addition of recombinant leptin (rLeptin). Cells were infected with a recombinant SARS-CoV-2 USA-WA1/2020 expressing enhanced GFP (ic-SARS-CoV-2-eGFP) following the addition of recombinant leptin. Cells were harvested and the percentage of eGFP + cells were counted by flow cytometry. (B) Relative gene expression of LEPR in A549-hACE2, A549-hACE2 LEPR- and A549-hACE2 CTL cells at 48h post-transfection. Bars represent the mean ± standard deviation. (C) Representative multiplex immunofluorescence staining of LEPR (green), human ACE2 (red), and nucleus (grey) in A549, A549-hACE2, A549-hACE2 LEPR- and A549-hACE2 CTL cells at 48h post-transfection (Scale bar: 20 μm). Percentage of eGFP + A549-hACE2 LEPR- and A549-hACE2 CTL cells at 12 hpi (D) , 24 hpi (E) , and 48 hpi (F) in the presence of 0, 10, and 100 ng/ml of rLeptin. The insets illustrate the fold change of eGFP + cells between A549-hACE2 LEPR- and A549-hACE2 CTL , both treated with 100 ng/mL of rLeptin, at 12 and 24 hpi. Bars represent the mean ± standard deviation of four independent experiments performed in triplicate. Each dot represents the average of the triplicate. Relative gene expression of IFNb1 in A549-hACE2 LEPR- and A549-hACE2 CTL at 12 hpi (G) and 24 hpi (H) demonstrated an increase of IFNb1 expression in A549-hACE2 LEPR- and with concurrent administration of rLeptin. Bars represent the mean ± standard deviation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001.
Article Snippet: Human lung carcinoma cells (A549; NR-52268) and A549 expressing human angiotensin-converting enzyme 2 (A549-hACE2; NR-53821) were obtained from BEI Resources (Manassas, VA) and were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco) supplemented with 10% FBS, 1% 1× non-essential amino acids (Gibco).
Techniques: Concentration Assay, In Vitro, Control, Recombinant, Infection, Expressing, Flow Cytometry, Gene Expression, Transfection, Standard Deviation, Multiplex Assay, Immunofluorescence, Staining